Lean non-alcoholic fatty liver disease: Is there a place for novel antidiabetics in the therapeutic management of this underappreciated “enemy”?
- Author:
Dimitrios PATOULIAS
1
;
Michael DOUMAS
Author Information
- Publication Type:Letter to the Editor
- From:Clinical and Molecular Hepatology 2020;26(4):582-583
- CountryRepublic of Korea
- Language:English
